Last reviewed · How we verify
NCT05604300
The Role of Vitamin E Incorporated Oat Supplementation in Metabolic Syndrome (MetS) Patients
NA trial testing Vitamin E incorporated oat supplement in Metabolic Syndrome in 81 participants. Completed in 30 November 2023.
30 June 2023
Quick facts
| Lead sponsor | Universiti Sains Malaysia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | supportive care |
| Enrollment | 81 |
| Start date | 1 June 2022 |
| Primary completion | 30 June 2023 |
| Estimated completion | 30 November 2023 |
| Sites | 1 location across Malaysia |
Drugs / interventions tested
- Vitamin E incorporated oat supplement
- Oat supplement
Conditions studied
- Metabolic Syndrome — all drugs for Metabolic Syndrome →
Sponsor
Universiti Sains Malaysia — full company profile →
Who can join
18 and older, any sex, with Metabolic Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to evaluate the effect of vitamin E incorporated oat supplementation among the metabolic syndrome (MetS) patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05604300
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Metabolic Syndrome
Currently open trials in the same condition.
- NCT07501858 — Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metaboli · recruiting
- NCT06857929 — "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" · NA · recruiting
- NCT07237750 — iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss · NA · recruiting
- NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
- NCT07383220 — Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure · NA · recruiting
Other Universiti Sains Malaysia trials
Trials by the same sponsor.
- NCT07397104 — Validity of a Self-reported Questionnaire for Periodontal Status in a Saudi Population · not yet recruiting
- NCT07279324 — Safety and Efficacy of Kelulut Honey Eyedrops in Dry Eye Disease · NA · not yet recruiting
- NCT07338045 — The Effects of Eight-Week Baduanjin Exercise on Chronic Low Back Pain and Disability Among Office Workers. · NA · not yet recruiting
- NCT07410351 — Development of A Self-Assessment Tool for Personalized Preventive Periodontal Care Among the Saudi Population Using Semi · not yet recruiting
- NCT07448909 — Cognitive-Frailty Gait Biomechanics for Early Dementia Detection · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05604300 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universiti Sains Malaysia
- Last refreshed: 8 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05604300.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing